Looking for hypertrophic cardiomyopathy in the community: why is it important?
- PMID: 20559997
- DOI: 10.1007/s12265-009-9135-4
Looking for hypertrophic cardiomyopathy in the community: why is it important?
Abstract
Hypertrophic cardiomyopathy (HCM) is an epidemiologically relevant, worldwide spread condition which is frequently perceived as a rare disease. This misconception might be supported by some characteristics of HCM such as its incomplete penetrance and variable age at onset and by the fact that many patients remain asymptomatic for a long course of the disease and are thus unlikely to seek for medical evaluation. Multiple evidences suggest that early diagnosis of HCM is important, not only because it allows the patients to be addressed to appropriate diagnostic work-out and to adequate therapeutical options but because it may trigger the screening of family members with the potential of further, new diagnosis of HCM in previously unsuspected individuals. Increased awareness of the disease among physicians working in community-based hospitals and in outpatients facilities, and a facilitated communication and access to tertiary referral centers, will result into a wider knowledge of the spectrum of the disease, a better access to the state-of-the-art management options for patients, and to a more diffuse practice of genetic evaluation of HCM families.
Similar articles
-
Genetic counseling and testing for hypertrophic cardiomyopathy: an adult perspective.J Cardiovasc Transl Res. 2009 Dec;2(4):493-9. doi: 10.1007/s12265-009-9127-4. Epub 2009 Sep 26. J Cardiovasc Transl Res. 2009. PMID: 20560007 Review.
-
A good idea: a physician's perspective on genetic counseling for hypertrophic cardiomyopathy.J Cardiovasc Transl Res. 2009 Dec;2(4):508-9. doi: 10.1007/s12265-009-9130-9. Epub 2009 Sep 30. J Cardiovasc Transl Res. 2009. PMID: 20560009 No abstract available.
-
A new era in clinical genetic testing for hypertrophic cardiomyopathy.J Cardiovasc Transl Res. 2009 Dec;2(4):381-91. doi: 10.1007/s12265-009-9139-0. Epub 2009 Oct 30. J Cardiovasc Transl Res. 2009. PMID: 20559996 Review.
-
Genetic counseling and testing for hypertrophic cardiomyopathy: the pediatric perspective.J Cardiovasc Transl Res. 2009 Dec;2(4):500-7. doi: 10.1007/s12265-009-9126-5. Epub 2009 Sep 24. J Cardiovasc Transl Res. 2009. PMID: 20560008
-
Familial Hypertrophic Cardiomyopathy: Diagnosis and Management.Vasc Health Risk Manag. 2023 Apr 6;19:211-221. doi: 10.2147/VHRM.S365001. eCollection 2023. Vasc Health Risk Manag. 2023. PMID: 37050929 Free PMC article. Review.
Cited by
-
Clinical Characteristics and Healthcare Resource Utilization among Patients with Obstructive Hypertrophic Cardiomyopathy Treated in a Range of Settings in the United States.J Clin Med. 2022 Jul 4;11(13):3898. doi: 10.3390/jcm11133898. J Clin Med. 2022. PMID: 35807183 Free PMC article.
-
Targeting miR-199a reduces fibrosis in hypertrophic cardiomyopathy.J Mol Cell Cardiol Plus. 2023 Dec 9;7:100057. doi: 10.1016/j.jmccpl.2023.100057. eCollection 2024 Mar. J Mol Cell Cardiol Plus. 2023. PMID: 39802443 Free PMC article. No abstract available.